Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 160

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 160
---
 assets 
    $463,011  
    $370,312 
  
    Operating lease liability, current 
     127,498  
     94,708 
  
    Operating lease liability,
    non-current 
     342,098  
     283,001 
  
    Total operating lease
    liabilities 
    $469,596  
    $377,709 

    Financing
    leases: 
    2024  
    2023 
  
    Financing lease right-of-use assets,
    gross 
    $1,294,168  
    $1,294,168 
  
    Accumulated amortization 
     (513,296) 
     (128,324)
  
    Finance lease right-of-use
    assets, net 
    $780,872  
    $1,165,844 
  
    Financing lease liability, current 
     395,301  
     365,463 
  
    Financing lease liability,
    non-current 
     444,448  
     835,467 
  
    Total finance lease
    liabilities 
    $839,749  
    $1,200,930 

    Weighted-average
    remaining lease term: 
    2024  
    2023 
  
    Operating leases (in years) 
     4.21  
     3.58 
  
    Finance leases (in years) 
     2.39  
     3.25 

    Weighted-average
    discount rate: 
    2024  
    2023 
  
    Operating leases 
     7.41% 
     8.07%
  
    Finance leases 
     8.03% 
     8.01%

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT UNDER NON-CANCELLABLE 

    Operating
    Leases  
    Finance
                                            Leases 
  
    2025 
    $157,837  
    $448,505 
  
    2026 
     159,282  
     270,395 
  
    2027 
     110,063  
     202,970 
  
    2028 
     40,616  
     — 
  
    2029 
     42,252  
     — 
  
    2030 and thereafter 
     28,919